Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wangbi capsule for knee osteoarthritis
ChiCTR2300068041Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Wangbi in knee osteoarthritis (OA) (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: WOMAC index. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
Wangbi
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300068041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068041.